KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Abbott Laboratories (ABT) Long-Term Debt Issuances (2018 - 2025)

Abbott Laboratories' Long-Term Debt Issuances history spans 9 years, with the latest figure at $2.0 million for Q4 2025.

  • For Q4 2025, Long-Term Debt Issuances rose 100.0% year-over-year to $2.0 million; the TTM value through Dec 2025 reached $5.0 million, down 97.76%, while the annual FY2025 figure was $5.0 million, 97.76% down from the prior year.
  • Long-Term Debt Issuances for Q4 2025 was $2.0 million at Abbott Laboratories, roughly flat from $2.0 million in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $221.0 million in Q2 2024 and bottomed at $1.0 million in Q3 2022.
  • The 5-year median for Long-Term Debt Issuances is $1.0 million (2022), against an average of $26.0 million.
  • The largest annual shift saw Long-Term Debt Issuances surged 300.0% in 2021 before it plummeted 99.1% in 2025.
  • A 5-year view of Long-Term Debt Issuances shows it stood at $4.0 million in 2021, then crashed by 75.0% to $1.0 million in 2022, then changed by 0.0% to $1.0 million in 2023, then changed by 0.0% to $1.0 million in 2024, then skyrocketed by 100.0% to $2.0 million in 2025.
  • Per Business Quant, the three most recent readings for ABT's Long-Term Debt Issuances are $2.0 million (Q4 2025), $2.0 million (Q2 2025), and $1.0 million (Q1 2025).